Drugs Affecting Body Weight and Fat Distribution
List of therapeutic drug classes that are associated with significant weight gain and changes in fat distribution (lipodystrophy) and metabolism.
List of therapeutic drug classes that are associated with significant weight gain and changes in fat distribution (lipodystrophy) and metabolism.
Three-quarters of all psychiatric disorders occur by early adulthood (mid-20s). This fact suggests that bio-psychosocial factors occurring from the fetal period through early adulthood could play a crucial role in risk. This nonsystematic review sought to synthesize key epidemiological evidence of relevant risk factors.
Investigators assessed differences in functional status and cardiometabolic risks among patients with HIV from multinational groups.
Researchers conducted a study to determine whether surgical intervention for weight loss decreases the risk for severe COVID-19.
There are significant race/ethnicity-associated differences in management of type 1 diabetes.
Similar decline in liver fat fraction seen for sleeve gastrectomy, Roux-en-Y gastric bypass from surgery to one-year follow-up.
Investigators assessed the association between diet quality and risk for and severity of COVID-19, as well as its relationship with socioeconomic deprivation.
People with familial hypercholesterolemia with COVID-19 risk endothelial dysfunction. Therapy should continue during the course of the virus.
Investigators conducted a study to determine the relationship between demographic characteristics and comorbidities on the risk of mortality in patients with COVID-19.
Researchers sought to identify which medications for type 2 diabetes may be associated with severity of COVID-19.